Company news

Sensei Biotherapeutics, Inc. news in 2022

Sensei Biotherapeutics, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Sensei Biotherapeutics Provides Update on Strategic Priorities

December 7, 2022

Sensei Biotherapeutics to Participate in the Piper Sandler 34th Annual Healthcare Conference

November 21, 2022

Sensei Biotherapeutics Announces Collaboration with Washington University, St. Louis to Support Development of SNS-101, a Conditionally Active VISTA-blocking Antibody

November 20, 2022

Sensei Biotherapeutics Presents Preclinical Data at the 37th Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 9, 2022

Sensei Biotherapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights

November 7, 2022

Sensei Biotherapeutics to Host Virtual Key Opinion Leader Webinar, “Lessons from VISTA: New Strategies to Address an Important Immune Checkpoint”

November 6, 2022

Sensei Biotherapeutics to Participate in the 13th Annual Jefferies Global Healthcare Conference

November 1, 2022

Sensei Biotherapeutics to Present New Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

October 4, 2022

Sensei Biotherapeutics Presents Preclinical Data for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Sixth Annual CRI-ENCI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival

September 29, 2022

Sensei Biotherapeutics to Present Preclinical Data for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Sixth Annual CRI-ENCI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival

September 20, 2022

Sensei Biotherapeutics Announces New Preclinical Data Demonstrating Favorable Pharmacokinetic and Immunologic Effects of SNS-101, a pH-selective VISTA-blocking Antibody

August 30, 2022

Sensei Biotherapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights

August 8, 2022

Sensei Biotherapeutics Appoints Patrick Gallagher, MBA, MPH, as Chief Business Officer

May 31, 2022

Sensei Biotherapeutics to Participate in Jefferies Healthcare Conference

May 24, 2022

Sensei Biotherapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights

May 9, 2022

Sensei Biotherapeutics Reports Full Year 2021 Financial Results and Business Highlights

March 9, 2022

Sensei Biotherapeutics Appoints William Ringo, MBA, as Chair of Board of Directors

March 8, 2022

Sensei Biotherapeutics to Participate in the 32nd Annual Oppenheimer Healthcare Conference

March 2, 2022

Sensei Biotherapeutics to Participate in Citi’s 2022 Virtual Immuno-Oncology Summit

February 10, 2022

Sensei Biotherapeutics Announces Executive Promotions

January 5, 2022

Decks in 2022